Peptide Therapeutics Market Size, Share and Forecast 2026
The Peptide Therapeutics market was valued at USD XX million in 2018 and expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.
(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
Peptides are a unique class of pharmaceutical compounds, molecularly poised between small molecules and proteins, yet biochemically and therapeutically distinct from both. Peptides are known for being highly selective and effective and, at the same time, relatively safe and well accepted. They are receiving growing interest as clinical therapeutics.
Market Dynamics:
The global market for the Peptide Therapeutics Market is primarily driven by the rising prevalence of infectious diseases, cancer and metabolic diseases such as obesity, diabetes and osteoporosis, coupled with the growing demand for effective drugs. However, the stringent regulations and the complexity in manufacturing of the peptides may hinder market progress.
Market Segmentation:
By Type
• Patented
• Generic
By Application
• Cancer
• Cardiovascular Diseases
• Metabolic Diseases
• Central Nervous System Disorders
• Respiratory Diseases
• Infectious Diseases
• Others (Renal Disorders, Gastrointestinal Diseases, Pain Management, Dermatological Disorders, And Hematological Disorders)
By Route of Administration
• Oral Route
• Parenteral Route
• Others
By Technology
• Solid Phase Peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Phase Peptide Synthesis (HPPS)
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Eli Lilly and Company
• Sanofi
• Takeda Pharmaceutical
• F. Hoffman-La Roche AG
• GlaxoSmithKline plc
• Bristol-Myers Squibb
• Others
View full report: https://www.datamintelligence.com/research-report/peptide-therapeutics-market
Download free sample: https://www.datamintelligence.com/download-sample/peptide-therapeutics-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Peptides are a unique class of pharmaceutical compounds, molecularly poised between small molecules and proteins, yet biochemically and therapeutically distinct from both. Peptides are known for being highly selective and effective and, at the same time, relatively safe and well accepted. They are receiving growing interest as clinical therapeutics.
Market Dynamics:
The global market for the Peptide Therapeutics Market is primarily driven by the rising prevalence of infectious diseases, cancer and metabolic diseases such as obesity, diabetes and osteoporosis, coupled with the growing demand for effective drugs. However, the stringent regulations and the complexity in manufacturing of the peptides may hinder market progress.
Market Segmentation:
By Type
• Patented
• Generic
By Application
• Cancer
• Cardiovascular Diseases
• Metabolic Diseases
• Central Nervous System Disorders
• Respiratory Diseases
• Infectious Diseases
• Others (Renal Disorders, Gastrointestinal Diseases, Pain Management, Dermatological Disorders, And Hematological Disorders)
By Route of Administration
• Oral Route
• Parenteral Route
• Others
By Technology
• Solid Phase Peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Phase Peptide Synthesis (HPPS)
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Eli Lilly and Company
• Sanofi
• Takeda Pharmaceutical
• F. Hoffman-La Roche AG
• GlaxoSmithKline plc
• Bristol-Myers Squibb
• Others
View full report: https://www.datamintelligence.com/research-report/peptide-therapeutics-market
Download free sample: https://www.datamintelligence.com/download-sample/peptide-therapeutics-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results